Advertisement
News
Advertisement

NeuroPace's epilepsy implant lands a date with the FDA after more than 2 years

Fri, 12/07/2012 - 1:22pm
Mass Device

More than 2 years after submitting its original premarket approval application, California device maker NeuroPace lands an FDA panel meeting to review its epilepsy-treating neuromodulation implant.

NeuroPace

California medical device maker NeuroPace is finally getting a date with the FDA to review its premarket application for a neuromodulation implant for patients with epilepsy.

NeuroPace filed its application in July 2010 for its RNS System, hoping to win indication as an adjunct therapy for reducing seizures in patients aged 18 and older.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading